Both systems are capable for diagnosing the Ischemic Cascade, thanks to several innovative techniques that help you quantify a variety of important cardiac functions. One example is FAM(TM) -- Free Angular M-Mode, which displays three M-Mode traces simultaneously -- in real time. What is typically a post-process procedure can now be done live.
Another innovative technique is Aloka's unique A-SMA(TM) technology, which allows you to assess both the diastolic and systolic phases of the heart. This gives you multiple channels of information related to cardiac wall motion on which to make a diagnosis. In addition, these systems have the capability to assess myocardial function with its TDI -- Tissue Doppler Imaging and Strain imaging analysis package.
TDI analysis, FAM and A-SMA are also useful for evaluating ventricular asynchrony, so you can determine the effectiveness of Cardiac Resynchronization Therapy, or "CRT." With these tools, and the ProSound's temporal resolution of more than 150 FPS in TDI mode, physicians can evaluate whether a patient is likely to respond to CRT before the therapy even begins.
David Famiglietti, Chief Operating Officer at Aloka, said, "We are excited to have such a powerful combination of products for the cardiac and vascular markets. With the outstanding overall performance of the ProSound Alpha 7 and Alpha 10, Aloka has taken a major step forward in expanding the many ultrasound applications and markets we serve."
"I am very impressed with the performance of Aloka's Alpha 10," said
Robert Reach, RDCS, a cardiac ultrasound sonographer at Piedmont Cardiology
in Hickory, NC, who has evaluated the system. "The grayscale imaging has
excellent detail and the quality of the color/Doppler is outstanding. The
ProSound Alpha 10 performs as well as or better than any other premium
|SOURCE Aloka Co., Ltd.|
Copyright©2007 PR Newswire.
All rights reserved